Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events

  Events

April 2013
Scientific News
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Computerized Flexible Needles Prove Themselves in Biological Tissue
The advantage of the system is that you can avoid obstacles with the needles or critical tissues and that the system during the insertion of the needle in real time can adjust the path if, for example, the tissue deforms.
DARWIN 2 24-week Monotherapy Data in RA Confirm Previous Results
Safety profile in DARWIN 2 consistent with previous filgotinib RA studies.
Researchers Publish Landmark “Basket Study”
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.
Agricultural Intervention Improves HIV Outcomes
A multifaceted farming intervention can reduce food insecurity while improving HIV outcomes in patients in Kenya, according to a randomized, controlled trial led by researchers at UC San Francisco.
Overdose of Vitamin D in Teenagers May Lead to Increased Cholesterol Levels
Dosing obese teens with vitamin D shows no benefits for their heart health or diabetes risk, and could have the unintended consequences of increasing cholesterol and fat-storing triglycerides. These are the latest findings in a series of Mayo Clinic studies in childhood obesity.
Phase 2 Trials Underway for New Single Dose Malaria Treatment
The new drug, which prevents the malaria parasite from reproducing and spreading, is now undergoing Phase II clinical trials in humans.
Promising Drug for Parkinson's Disease
A drug which has already been in use for decades to treat liver disease could be an effective treatment to slow down progression of Parkinson’s disease, scientists from the University of Sheffield have discovered.
16 Apr 2013 - 18 Apr 2013
PA, USA
4th Medical Affairs Executive Forum
17 Apr 2013 - 18 Apr 2013
London, UK
Pharmaceutical Portfolio & Lifecycle Management
6th Annual CIS & SEE Clinical Trials Forum
18 Apr 2013 - 19 Apr 2013
Zagreb, Croatia
6th Annual CIS & SEE Clinical Trials Forum
21 Apr 2013 - 24 Apr 2013
• Marriott World Center• Orlando, FL
22nd Annual Partnerships in Clinical Trials
Digital Pharma Canada
22 Apr 2013 - 23 Apr 2013
Toronto, ON, Canada
Digital Pharma Canada
4th Annual National Summit On Strategic Communications
22 Apr 2013 - 23 Apr 2013
Washington DC, USA
4th Annual National Summit On Strategic Communications
2nd Digital Marketing for Medical Devices West
29 Apr 2013 - 01 May 2013
San Diego, CA, USA
2nd Digital Marketing for Medical Devices West
Clinical Billing Boot Camp - San Diego
29 Apr 2013 - 01 May 2013
San Diego, CA, USA
Clinical Billing Boot Camp - San Diego


<< 1 2 >>
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!